<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 4.14a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: ctix%2D20161231_10Q2.xfr; Date: 2017%2D02%2D08T14:21:11Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x80080000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://cellceutix.com/role/Documentdocumentandentityinformation" xlink:href="ctix-20161231.xsd#Documentdocumentandentityinformation" xlink:type="simple" />
    <link:roleRef roleURI="http://cellceutix.com/role/Condensedbalancesheets" xlink:href="ctix-20161231.xsd#Condensedbalancesheets" xlink:type="simple" />
    <link:roleRef roleURI="http://cellceutix.com/role/CondensedBalanceSheetsParenthetical" xlink:href="ctix-20161231.xsd#CondensedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://cellceutix.com/role/Condensedstatementsofoperationsunaudited" xlink:href="ctix-20161231.xsd#Condensedstatementsofoperationsunaudited" xlink:type="simple" />
    <link:roleRef roleURI="http://cellceutix.com/role/CondensedConsolidatedStatementsOfCashFlow" xlink:href="ctix-20161231.xsd#CondensedConsolidatedStatementsOfCashFlow" xlink:type="simple" />
    <link:roleRef roleURI="http://cellceutix.com/role/BasisOfPresentationAndNatureOfOperations" xlink:href="ctix-20161231.xsd#BasisOfPresentationAndNatureOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://cellceutix.com/role/NotesToFinancialStatementsGoingConcernDisclosureTextBlock" xlink:href="ctix-20161231.xsd#NotesToFinancialStatementsGoingConcernDisclosureTextBlock" xlink:type="simple" />
    <link:roleRef roleURI="http://cellceutix.com/role/SignificantAccountingPolicies" xlink:href="ctix-20161231.xsd#SignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://cellceutix.com/role/PatentsNet" xlink:href="ctix-20161231.xsd#PatentsNet" xlink:type="simple" />
    <link:roleRef roleURI="http://cellceutix.com/role/AccountsPayable" xlink:href="ctix-20161231.xsd#AccountsPayable" xlink:type="simple" />
    <link:roleRef roleURI="http://cellceutix.com/role/AccruedExpenses" xlink:href="ctix-20161231.xsd#AccruedExpenses" xlink:type="simple" />
    <link:roleRef roleURI="http://cellceutix.com/role/AccruedSalariesAndPayrollTaxesRelatedParties" xlink:href="ctix-20161231.xsd#AccruedSalariesAndPayrollTaxesRelatedParties" xlink:type="simple" />
    <link:roleRef roleURI="http://cellceutix.com/role/NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlock" xlink:href="ctix-20161231.xsd#NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlock" xlink:type="simple" />
    <link:roleRef roleURI="http://cellceutix.com/role/NotesToFinancialStatementsRelatedPartyTransactionsDisclosureTextBlock" xlink:href="ctix-20161231.xsd#NotesToFinancialStatementsRelatedPartyTransactionsDisclosureTextBlock" xlink:type="simple" />
    <link:roleRef roleURI="http://cellceutix.com/role/NotePayableRelatedParty" xlink:href="ctix-20161231.xsd#NotePayableRelatedParty" xlink:type="simple" />
    <link:roleRef roleURI="http://cellceutix.com/role/EquityIncentivePlansStock-basedCompensationAndWarrants" xlink:href="ctix-20161231.xsd#EquityIncentivePlansStock-basedCompensationAndWarrants" xlink:type="simple" />
    <link:roleRef roleURI="http://cellceutix.com/role/StockTransactions" xlink:href="ctix-20161231.xsd#StockTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://cellceutix.com/role/SubsequentEvents" xlink:href="ctix-20161231.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://cellceutix.com/role/SignificantAccountingPoliciesPolicies" xlink:href="ctix-20161231.xsd#SignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://cellceutix.com/role/SignificantAccountingPoliciesAndRecentAccountingPronouncementsTables" xlink:href="ctix-20161231.xsd#SignificantAccountingPoliciesAndRecentAccountingPronouncementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://cellceutix.com/role/PatentsnetTables" xlink:href="ctix-20161231.xsd#PatentsnetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://cellceutix.com/role/AccountsPayableTables" xlink:href="ctix-20161231.xsd#AccountsPayableTables" xlink:type="simple" />
    <link:roleRef roleURI="http://cellceutix.com/role/AccruedExpensesTables" xlink:href="ctix-20161231.xsd#AccruedExpensesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://cellceutix.com/role/AccruedSalariesandPayrollTaxesRelatedPartiesTables" xlink:href="ctix-20161231.xsd#AccruedSalariesandPayrollTaxesRelatedPartiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://cellceutix.com/role/CommitmentsAndContingenciesTables" xlink:href="ctix-20161231.xsd#CommitmentsAndContingenciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://cellceutix.com/role/StockOptionsandWarrantsTables" xlink:href="ctix-20161231.xsd#StockOptionsandWarrantsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://cellceutix.com/role/StockTransactionsTables" xlink:href="ctix-20161231.xsd#StockTransactionsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://cellceutix.com/role/LiquidityDetailsNarrative" xlink:href="ctix-20161231.xsd#LiquidityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://cellceutix.com/role/SignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails" xlink:href="ctix-20161231.xsd#SignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://cellceutix.com/role/SignificantAccountingPoliciesAndRecentAccountingPronouncementsDetailsTextual" xlink:href="ctix-20161231.xsd#SignificantAccountingPoliciesAndRecentAccountingPronouncementsDetailsTextual" xlink:type="simple" />
    <link:roleRef roleURI="http://cellceutix.com/role/PatentsnetDetails" xlink:href="ctix-20161231.xsd#PatentsnetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://cellceutix.com/role/PatentsNetDetailsTextual" xlink:href="ctix-20161231.xsd#PatentsNetDetailsTextual" xlink:type="simple" />
    <link:roleRef roleURI="http://cellceutix.com/role/AccountsPayableDetails" xlink:href="ctix-20161231.xsd#AccountsPayableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://cellceutix.com/role/AccountsPayableDetailsNarrative" xlink:href="ctix-20161231.xsd#AccountsPayableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://cellceutix.com/role/AccruedExpensesSummaryOfAccruedExpensesDetails" xlink:href="ctix-20161231.xsd#AccruedExpensesSummaryOfAccruedExpensesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://cellceutix.com/role/AccruedSalariesAndPayrollTaxesRelatedPartiesSummaryOfAccruedSalariesAndPayrollTaxesDetails" xlink:href="ctix-20161231.xsd#AccruedSalariesAndPayrollTaxesRelatedPartiesSummaryOfAccruedSalariesAndPayrollTaxesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://cellceutix.com/role/CommitmentsAndContingenciesDetails" xlink:href="ctix-20161231.xsd#CommitmentsAndContingenciesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://cellceutix.com/role/CommitmentsAndContingenciesDetailTextuals2" xlink:href="ctix-20161231.xsd#CommitmentsAndContingenciesDetailTextuals2" xlink:type="simple" />
    <link:roleRef roleURI="http://cellceutix.com/role/RelatedPartyTransactionsDetailTextuals" xlink:href="ctix-20161231.xsd#RelatedPartyTransactionsDetailTextuals" xlink:type="simple" />
    <link:roleRef roleURI="http://cellceutix.com/role/NotePayableRelatedPartyDetailTextuals" xlink:href="ctix-20161231.xsd#NotePayableRelatedPartyDetailTextuals" xlink:type="simple" />
    <link:roleRef roleURI="http://cellceutix.com/role/EquityIncentivePlansStock-basedCompensationAndWarrantsDetails" xlink:href="ctix-20161231.xsd#EquityIncentivePlansStock-basedCompensationAndWarrantsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://cellceutix.com/role/EquityIncentivePlansStock-basedCompensationAndWarrantsDetails1" xlink:href="ctix-20161231.xsd#EquityIncentivePlansStock-basedCompensationAndWarrantsDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://cellceutix.com/role/StockOptionsAndWarrantsOptionsOutstandingAndExercisableDetails1" xlink:href="ctix-20161231.xsd#StockOptionsAndWarrantsOptionsOutstandingAndExercisableDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://cellceutix.com/role/StockOptionsAndWarrantsDetailTextuals2" xlink:href="ctix-20161231.xsd#StockOptionsAndWarrantsDetailTextuals2" xlink:type="simple" />
    <link:roleRef roleURI="http://cellceutix.com/role/StockTransactionsDetails" xlink:href="ctix-20161231.xsd#StockTransactionsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://cellceutix.com/role/StockTransactionsDetails1" xlink:href="ctix-20161231.xsd#StockTransactionsDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://cellceutix.com/role/StockTransactionsDetailsTextual" xlink:href="ctix-20161231.xsd#StockTransactionsDetailsTextual" xlink:type="simple" />
    <link:roleRef roleURI="http://cellceutix.com/role/SubsequentEventsDetailsNarrative" xlink:href="ctix-20161231.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cellceutix.com/role/Documentdocumentandentityinformation" xlink:title="00000001 - Document - Document and Entity Information" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cellceutix.com/role/Condensedbalancesheets" xlink:title="00000002 - Statement - CONDENSED BALANCE SHEETS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCash" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ctix-20161231.xsd#ctix_SubscriptionReceivable" xlink:label="loc_ctixSubscriptionReceivable" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_ctixSubscriptionReceivable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssets" xlink:label="loc_us-gaapOtherAssets" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredOfferingCosts" xlink:label="loc_us-gaapDeferredOfferingCosts" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherAssets" xlink:to="loc_us-gaapDeferredOfferingCosts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherAssets" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherAssets" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepositsAssets" xlink:label="loc_us-gaapDepositsAssets" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherAssets" xlink:to="loc_us-gaapDepositsAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOtherAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xlink:label="loc_us-gaapNotesPayableRelatedPartiesClassifiedCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapNotesPayableRelatedPartiesClassifiedCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://cellceutix.com/role/CondensedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONDENSED BALANCE SHEETS (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cellceutix.com/role/Condensedstatementsofoperationsunaudited" xlink:title="00000004 - Statement - CONDENSED STATEMENTS OF OPERATIONS (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LaborAndRelatedExpense" xlink:label="loc_us-gaapLaborAndRelatedExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapLaborAndRelatedExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaapProfessionalFees" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapProfessionalFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapRevenues" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="loc_us-gaapInvestmentIncomeInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInvestmentIncomeInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://cellceutix.com/role/CondensedConsolidatedStatementsOfCashFlow" xlink:title="00000005 - Statement - CONDENSED STATEMENTS OF CASH FLOW (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayable" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInEmployeeRelatedLiabilities" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInEmployeeRelatedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ctix-20161231.xsd#ctix_IssuanceOfStockAndStockOptionsForServicesCompensationRenderedAndCharitableContributions" xlink:label="loc_ctixIssuanceOfStockAndStockOptionsForServicesCompensationRenderedAndCharitableContributions" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_ctixIssuanceOfStockAndStockOptionsForServicesCompensationRenderedAndCharitableContributions" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperations" />
      <link:loc xlink:type="locator" xlink:href="ctix-20161231.xsd#ctix_AdditionsToPropertyPlantAndEquipment" xlink:label="loc_ctixAdditionsToPropertyPlantAndEquipment" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="loc_ctixAdditionsToPropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperations" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaapProceedsFromStockOptionsExercised" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="loc_us-gaapProceedsFromStockOptionsExercised" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashPeriodIncreaseDecrease" xlink:label="loc_us-gaapCashPeriodIncreaseDecrease" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://cellceutix.com/role/BasisOfPresentationAndNatureOfOperations" xlink:title="00000006 - Disclosure - Basis of Presentation and Nature of Operations" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cellceutix.com/role/NotesToFinancialStatementsGoingConcernDisclosureTextBlock" xlink:title="00000007 - Disclosure - Liquidity" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cellceutix.com/role/SignificantAccountingPolicies" xlink:title="00000008 - Disclosure - Significant Accounting Policies and Recent Accounting Pronouncements" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cellceutix.com/role/PatentsNet" xlink:title="00000009 - Disclosure - Patents, net" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cellceutix.com/role/AccountsPayable" xlink:title="00000010 - Disclosure - Accounts Payable" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cellceutix.com/role/AccruedExpenses" xlink:title="00000011 - Disclosure - Accrued Expenses" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cellceutix.com/role/AccruedSalariesAndPayrollTaxesRelatedParties" xlink:title="00000012 - Disclosure - Accrued Salaries and Payroll Taxes - Related Parties And Other" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cellceutix.com/role/NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlock" xlink:title="00000013 - Disclosure - Commitments and Contingencies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cellceutix.com/role/NotesToFinancialStatementsRelatedPartyTransactionsDisclosureTextBlock" xlink:title="00000014 - Disclosure - Related Party Transactions" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cellceutix.com/role/NotePayableRelatedParty" xlink:title="00000015 - Disclosure - Note Payable-Related Party" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cellceutix.com/role/EquityIncentivePlansStock-basedCompensationAndWarrants" xlink:title="00000016 - Disclosure - Equity Incentive Plans, Stock-Based Compensation and Warrants" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cellceutix.com/role/StockTransactions" xlink:title="00000017 - Disclosure - Equity Transactions" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cellceutix.com/role/SubsequentEvents" xlink:title="00000018 - Disclosure - Subsequent Events" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cellceutix.com/role/SignificantAccountingPoliciesPolicies" xlink:title="00000019 - Disclosure - Significant Accounting Policies and Recent Accounting Pronouncements (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cellceutix.com/role/SignificantAccountingPoliciesAndRecentAccountingPronouncementsTables" xlink:title="00000020 - Disclosure - Significant Accounting Policies and Recent Accounting Pronouncements (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cellceutix.com/role/PatentsnetTables" xlink:title="00000021 - Disclosure - Patents, net (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cellceutix.com/role/AccountsPayableTables" xlink:title="00000022 - Disclosure - Accounts Payable (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cellceutix.com/role/AccruedExpensesTables" xlink:title="00000023 - Disclosure - Accrued Expenses (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cellceutix.com/role/AccruedSalariesandPayrollTaxesRelatedPartiesTables" xlink:title="00000024 - Disclosure - Accrued Salaries and Payroll Taxes - Related Parties And Other (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cellceutix.com/role/CommitmentsAndContingenciesTables" xlink:title="00000025 - Disclosure - Commitments and Contingencies (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cellceutix.com/role/StockOptionsandWarrantsTables" xlink:title="00000026 - Disclosure - Equity Incentive Plans, Stock-Based Compensation and Warrants (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cellceutix.com/role/StockTransactionsTables" xlink:title="00000027 - Disclosure - Equity Transactions (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cellceutix.com/role/LiquidityDetailsNarrative" xlink:title="00000028 - Disclosure - Liquidity (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cellceutix.com/role/SignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails" xlink:title="00000029 - Disclosure - Significant Accounting Policies and Recent Accounting Pronouncements (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cellceutix.com/role/SignificantAccountingPoliciesAndRecentAccountingPronouncementsDetailsTextual" xlink:title="00000030 - Disclosure - Significant Accounting Policies and Recent Accounting Pronouncements (Detail Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cellceutix.com/role/PatentsnetDetails" xlink:title="00000031 - Disclosure - Patents, net (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cellceutix.com/role/PatentsNetDetailsTextual" xlink:title="00000032 - Disclosure - Patents, net (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cellceutix.com/role/AccountsPayableDetails" xlink:title="00000033 - Disclosure - Accounts Payable (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cellceutix.com/role/AccountsPayableDetailsNarrative" xlink:title="00000034 - Disclosure - Accounts Payable (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cellceutix.com/role/AccruedExpensesSummaryOfAccruedExpensesDetails" xlink:title="00000035 - Disclosure - Accrued Expenses (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrentAndNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="ctix-20161231.xsd#ctix_AccruedConsultingFeeCurrent" xlink:label="loc_ctixAccruedConsultingFeeCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="loc_ctixAccruedConsultingFeeCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedRentCurrent" xlink:label="loc_us-gaapAccruedRentCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="loc_us-gaapAccruedRentCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestPayableCurrent" xlink:label="loc_us-gaapInterestPayableCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="loc_us-gaapInterestPayableCurrent" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://cellceutix.com/role/AccruedSalariesAndPayrollTaxesRelatedPartiesSummaryOfAccruedSalariesAndPayrollTaxesDetails" xlink:title="00000036 - Disclosure - Accrued Salaries and Payroll Taxes - Related Parties And Other (Details)">
      <link:loc xlink:type="locator" xlink:href="ctix-20161231.xsd#ctix_AccruedSalariesPayrollTaxes" xlink:label="loc_ctixAccruedSalariesPayrollTaxes" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="loc_us-gaapAccruedSalariesCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ctixAccruedSalariesPayrollTaxes" xlink:to="loc_us-gaapAccruedSalariesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedPayrollTaxesCurrent" xlink:label="loc_us-gaapAccruedPayrollTaxesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ctixAccruedSalariesPayrollTaxes" xlink:to="loc_us-gaapAccruedPayrollTaxesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ctix-20161231.xsd#ctix_WithholdingTaxRelatedParties" xlink:label="loc_ctixWithholdingTaxRelatedParties" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ctixAccruedSalariesPayrollTaxes" xlink:to="loc_ctixWithholdingTaxRelatedParties" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://cellceutix.com/role/CommitmentsAndContingenciesDetails" xlink:title="00000037 - Disclosure - Commitments and Contingencies (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDue" xlink:label="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDue" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueCurrent" xlink:label="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDue" xlink:to="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueInTwoYears" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDue" xlink:to="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueInTwoYears" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueInThreeYears" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDue" xlink:to="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueInThreeYears" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://cellceutix.com/role/CommitmentsAndContingenciesDetailTextuals2" xlink:title="00000038 - Disclosure - Commitments and Contingencies (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cellceutix.com/role/RelatedPartyTransactionsDetailTextuals" xlink:title="00000039 - Disclosure - Related Party Transactions (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cellceutix.com/role/NotePayableRelatedPartyDetailTextuals" xlink:title="00000040 - Disclosure - Note Payable - Related Party (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cellceutix.com/role/EquityIncentivePlansStock-basedCompensationAndWarrantsDetails" xlink:title="00000041 - Disclosure - Equity Incentive Plans, Stock-Based Compensation and Warrants (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cellceutix.com/role/EquityIncentivePlansStock-basedCompensationAndWarrantsDetails1" xlink:title="00000042 - Disclosure - Equity Incentive Plans, Stock-Based Compensation and Warrants (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cellceutix.com/role/StockOptionsAndWarrantsOptionsOutstandingAndExercisableDetails1" xlink:title="00000043 - Disclosure - Equity Incentive Plans, Stock-Based Compensation and Warrants (Details 2)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cellceutix.com/role/StockOptionsAndWarrantsDetailTextuals2" xlink:title="00000044 - Disclosure - Equity Incentive Plans, Stock-Based Compensation and Warrants (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cellceutix.com/role/StockTransactionsDetails" xlink:title="00000045 - Disclosure - Equity Transactions (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cellceutix.com/role/StockTransactionsDetails1" xlink:title="00000046 - Disclosure - Equity Transactions (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cellceutix.com/role/StockTransactionsDetailsTextual" xlink:title="00000047 - Disclosure - Equity Transactions (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cellceutix.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000048 - Disclosure - Subsequent Events (Details Narrative)" />
</link:linkbase>


